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Abstract
Minimally invasive fetal interven-
tions require accurate imaging from
inside the uterine cavity. Twin-to-
twin transfusion syndrome (TTTS), a
condition considered in this study,
occurs from abnormal vascular anas-
tomoses in the placenta that allow
blood to flow unevenly between the
fetuses. Currently, TTTS is treated
fetoscopically by identifying the
anastomosing vessels, and then per-
forming laser photocoagulation.
However, white light fetoscopy provides limited visibility of placental vascula-
ture, which can lead to missed anastomoses or incomplete photocoagulation.
Photoacoustic (PA) imaging is an alternative imaging method that provides
contrast for hemoglobin, and in this study, two PA systems were used to visual-
ize chorionic (fetal) superficial and subsurface vasculature in human placentas.
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The first system comprised an optical parametric oscillator for PA excitation
and a 2D Fabry-Pérot cavity ultrasound sensor; the second, light emitting diode
arrays and a 1D clinical linear-array ultrasound imaging probe. Volumetric
photoacoustic images were acquired from ex vivo normal term and TTTS-
treated placentas. It was shown that superficial and subsurface branching
blood vessels could be visualized to depths of approximately 7 mm, and that
ablated tissue yielded negative image contrast. This study demonstrated the
strong potential of PA imaging to guide minimally invasive fetal therapies.
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1 | INTRODUCTION
The human placenta is the interface between the mother
and the developing fetus, delivering the nutrients and
oxygen vital for normal growth and development [1]. In
monochorionic twin pregnancies, conditions such as
selective fetal growth restriction and twin-to-twin trans-
fusion syndrome (TTTS) are associated with specific
placental angioarchitectural patterns [2, 3]. TTTS, a
condition considered in this study, occurs from an
imbalance of blood flow across inter-twin vascular anas-
tomoses in the placenta; it is associated with a high risk
(80%–90%) of perinatal mortality if left untreated [4].
Minimally-invasive fetoscopic laser photocoagulation of
the vascular anastomoses is used to treat TTTS [5–7]. In
current clinical practice, two imaging modalities are
used during the intervention: B-mode ultrasound
(US) imaging to guide instruments from outside the
mother into the uterus to the placenta, and white light
fetoscopy within the uterus to identify vascular anasto-
moses on the chorionic (fetal) placental surface for
photocoagulation. However, both of these modalities
provide insufficient contrast to visualize small anasto-
mosing vessels beneath the chorionic placental surface
[8]. Missed anastomoses or incomplete photocoagulation
are associated with an increased risk of recurrent TTTS,
intrauterine fetal death and twin anemia polycythaemia
sequence [9–12]. With the procedural aim of occluding
all anastomoses and thereby separating the twins' circu-
lations, the “Solomon technique” involves photocoagula-
tion of the entire vascular equator [12, 13]. In one
randomized control trial, complete coagulation of the
entire vascular equator significantly reduced postopera-
tive fetal morbidity, as compared with selective occlu-
sion [13]. However, residual anastomoses remained in
around 20% of placentas; while this technique is very
promising, there is room for refinement. Advancements
in methods for imaging placental vasculature in vivo
[14, 15] could lead to significant improvements in the
treatment of TTTS.
Photoacoustic (PA) imaging is an emerging imag-
ing modality that provides molecular contrast from
the optical absorption of excitation light [16–18]. With
PA imaging, contrast from vasculature can be particu-
larly prominent due to optical absorption by hemoglo-
bin, as observed in many clinical contexts [19–28]. PA
imaging has been used to measure in vivo placental
oxygenation under conditions of maternal hypoxia and
hyperoxygenation [29] and preeclampsia [30] in rats,
and in pregnancies associated with hypertension and
fetal growth restriction in mice [31] respectively. Pre-
viously, two-dimensional (2D) PA images were
acquired from ex vivo healthy term singleton human
placentas with a clinical linear-array US imaging
probe and delivery of excitation light through an opti-
cal fiber adjacent to the placenta [32, 33]. This data
provided an initial demonstration that human chori-
onic placental vessels can be visualized with 2D PA
imaging. In the present study, we performed three-
dimensional (3D) PA imaging of two ex vivo human
placentas: a normal, term placenta and a placenta
from an identical twin pregnancy complicated by
TTTS and treated with photocoagulation in utero. The
motivations for our investigations were twofold: first,
to explore the potential of PA imaging of postpartum
placentas for improving our understanding of TTTS
and the effects of photocoagulation; second, to appre-
ciate what information may be available from
intraoperative PA imaging, with future probes that
would be suitable for intrauterine imaging. The nor-
mal and TTTS-treated placentas were first imaged
postpartum using a reference Fabry-Pérot (F-P) based
planar sensor PA imaging system, and subsequently
with a portable dual-modality PA/US imaging system
based on a clinical linear-array US imaging probe that
was mechanically scanned to create 3D images.
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2 | MATERIALS AND METHODS
2.1 | Human placentas
The placentas were obtained with written informed consent
after caesarean section deliveries at University College
London NHS Foundation Trust and Lister (East and North
Hertfordshire NHS Trust) Hospitals. The Bloomsbury
National Research Ethics Service Committee London
approved the study (14/LO/0863). The umbilical cords were
clamped immediately after delivery to preserve the blood
inside the vessels. Once the placenta separates from the uter-
ine myometrium after birth, the intervillous space into which
maternal blood circulates under low pressure collapses.
Clamping the umbilical cord at the birth of the baby pre-
serves the fetal blood compartment inside the fetal vessels.
Blood can leak out if structural damage occurs to the fetal
vessels in the placenta during delivery. The normal, term pla-
centa was delivered after an uncomplicated pregnancy at
38 weeks +6 days gestational age (GA). The patient who pro-
vided the identical twin placenta was successfully treated for
TTTS at 16 weeks +4 days GA using fetoscopic laser ablation
by complete coagulation of the entire vascular equator, and
was then delivered by planned Caesarean section at
34 weeks GA. Imaging was performed in several locations
on the chorionic surface within 1 to 4 hours of delivery.
2.2 | Fabry-Pérot-based planar sensor PA
imaging system
The first PA imaging system used for placental imaging com-
prises an optical parametric oscillator (OPO) to deliver exci-
tation light and a planar F-P sensor for ultrasound reception
(measured −3 dB acoustic bandwidth: 22 MHz [34];
Figure 1A). The operating principles of this reference
approach have previously been described in detail [34–36].
The F-P ultrasound sensor consists of a transparent polymer
film spacer sandwiched between two mirrors. The thickness
of this spacer is modulated by impinging ultrasound waves,
which in turn modulate the optical reflectivity of the sensor.
These modulations were measured using a continuous wave
interrogation laser beam that was raster-scanned across
the surface of the F-P sensor. The mirrors of the F-P sen-
sor were designed to be transparent at the wavelength of
the excitation light pulses (Figure 1A). All images were
obtained using an excitation wavelength of 760 nm and
a fluence below 2.5 mJ/cm2. The excitation light wave-
length was chosen to optimize the balance between con-
trast and penetration depth. For the normal term
placenta, a fiber-coupled Nd:YAG pumped OPO
(Spitlight 600, InnoLas Laser GmbH, Krailling, Ger-
many) operating at 30 Hz was used. For the TTTS-
treated placenta, a different OPO (InnoLas Laser GmbH,
Krailling, Germany) operating at 200 Hz was used. The
PA imaging system has a lateral field of view
of 14 mm × 14 mm, a depth-dependent spatial resolu-
tion in the range of 50 to 125 μm, and a typical tissue
penetration depth of approximately 10 mm, depending
on the excitation light wavelength.
Image reconstruction was performed using a frequency-
domain algorithm implemented with the “k-wave” Matlab
toolbox [37], using a sound speed of 1540 or 1560 m/s. This
variation in the optimal speed of sound used for recon-
struction may have originated from differences in the
samples' temperatures. Post-processing steps, including
normalizing image intensity with depth, were previously
described by Jathoul et al [35]. The reconstructed images
were displayed as depth color-coded maximum intensity
projections (MIPs) along different dimensions (x-y: lat-
eral dimensions; z: depth dimension). Although this
FIGURE 1 Photoacoustic imaging experimental setups. A,
Fabry-Pérot-based planar sensor PA imaging system. The sensor
head gently touched the placenta from the chorionic (fetal) surface,
with ultrasound (US) gel placed in between the sensor and the
tissue for acoustic coupling. B, Clinical linear-array ultrasound
probe-based PA imaging system. The US imaging probe with light
emitting diode (LED) arrays was translated across the placenta
using a linear motorized stage. The placenta was coated with US
gel, covered with a plastic membrane (cling film) and placed inside
a water-filled container. The plastic membrane minimized leakage
of blood from the placenta to the water above it
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FIGURE 2 Photoacoustic (PA) images of the chorionic placental vasculature of a normal term placenta. The 3D PA images were
obtained from two locations (white and cyan dashed squares) using the Fabry-Pérot-based planar sensor PA imaging system. They are
displayed as maximum intensity projections of the reconstructed 3D image volume. The scale bar applies to all PA images. Superficial
chorionic blood vessels are apparent in both x-y PA images, A, and the corresponding photograph, B. Several subsurface structures
that could be attributed to blood vessels are visible down to a depth of approximately 7 mm from the chorionic fetal surface of the
placenta
FIGURE 3 Photoacoustic (PA) images of the chorionic placental vasculature of an identical twin placenta treated for TTTS using laser
photocoagulation of the placental vascular equator. The 3D PA images were obtained using a Fabry-Pérot-based PA scanner and are
displayed as maximum intensity projections of the reconstructed 3D image volume. The images are arranged as a mosaic to capture a wider
area of the placenta. Superficial blood vessels are clearly resolved, A, which correspond well to those apparent in the photograph, B
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display typically incurs some information loss, the full
3D volumetric datasets were saved and exported in
DICOM format. Efforts were made to apply a minimum
of pressure to position the sensor onto the placenta;
ultrasound gel between the sensor and placenta was used
for acoustic coupling.
2.3 | Clinical linear-array ultrasound
probe-based PA imaging system
The second PA imaging system used for placental imaging
acquired co-registered PA and B-mode US images with a
clinical linear-array US imaging probe (AcousticX,
CYBERDYNE INC., Tsukuba, Japan) [38–40]. Excitation
light for PA imaging was provided by two light emitting
diode (LED) arrays (850 nm wavelength; 200 μJ nominal
pulse energy per array; 4 kHz pulse repetition frequency)
positioned on opposite sides of the imaging probe. The exci-
tation light wavelength of 850 nm was chosen due to the
availability of this LED array. The probe has a central fre-
quency of 9 MHz, 128 elements with a 300 μm pitch and a
nominal −6 dB acoustic bandwidth of 77% [40] (Figure 1B).
This probe provides a PA spatial resolution of 0.22
± 0.01 mm and 0.46 ± 0.06 mm across the axial and lateral
dimension respectively, as characterized previously by Xia
et al [40]. 3D PA imaging was enabled with translation of
the imaging probe with a linear motorized stage supplied
with the system (OSMS20-85[X], OptoSigma Corporation,
California). The translated distance during each 3D volume
acquisition was 10 mm. Concatenation of these 3D volumes
yielded a field of view of 38 mm × 60 mm. Upsampling (3×)
in the lateral dimension of the raw data and offline PA
image reconstruction was performed using a frequency-
domain algorithm implemented with the “k-wave” Matlab
toolbox [37] and a sound speed of 1540 m/s. The placenta
was initially placed in a plastic container, coated with ultra-
sound gel for acoustic coupling and covered with a plastic
membrane (cling film). The container was then filled with
water at room temperature for acoustic coupling, and for
free translation of the US imaging probe.
2.4 | Histology
A portion of the placenta treated for TTTS that included
photocoagulated (scar) tissue resulting from the laser
photocoagulation was dissected into a 15 mm × 15 mm
full thickness block, which was fixed in formalin for a
minimum of 48 hours and processed into paraffin wax
block. One full thickness section (10 μm thick) was sta-
ined with hematoxylin and eosin (H&E) for histological
FIGURE 4 Wide-field field photoacoustic (PA) and
ultrasound (US) images of the chorionic placental vasculature in an
untreated part of a TTTS photocoagulated placenta. The PA and US
images were acquired using the clinical linear-array US probe-
based PA imaging system. A, a 2D PA and a 2D US image, acquired
from a region corresponding to the purple line in, B, are merged
and displayed in a grayscale and a color-scale, respectively. Several
superficial blood vessels (red arrows) are visible in this 2D PA
image but not clearly visible in the 2D US image; they correspond
well to those apparent in the photograph, B. A prominent signal
from the 2D PA image (solid blue arrow) was not apparent in the
photograph, B. Additionally, a fluid-filled cavity (orange star; 2D
US image) was not visible in the 2D PA image. The placenta was
covered with a cling film membrane (yellow arrow). The images are
displayed on logarithmic scales. C, 3D PA image displayed as a
maximum intensity projection of the reconstructed image volume,
which was acquired by linear translation of the US probe.
Superficial chorionic structures are clearly resolved, with good
correspondence to the vessels apparent in the photograph, B
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assessment and micrographs at 40× and 100× magnifica-
tions were obtained.
3 | RESULTS
3.1 | Chorionic placental vasculature
Superficial chorionic placental vessels were clearly visualized
using the F-P based PA imaging system (Figure 2A). Good
correspondence between the MIP PA images and the photo-
graph (Figure 2B) was observed. Several subsurface objects,
which could be attributed to blood vessels, were visible to a
depth of approximately 7 mm from the chorionic fetal
surface of the placenta. The smallest resolved subsurface vas-
cular features were approximately 120 μm in diameter.
Manual mosaicking of 3D PA images, acquired from
multiple locations of the chorionic placental vasculature of
the TTTS-treated placenta, allowed for a broader region of
the placenta to be visualized (Figure 3). Superficial blood
vessels were clearly resolved (Figure 3A), which cor-
responded well to those apparent in the photograph
(Figure 3B). Subsurface vascular structures that were not vis-
ible in the photograph were apparent in the PA images to an
approximate depth of 3 mm (Figure 3A; location 6).
Wide-field PA images and US images of the chorionic
placental vasculature of the placenta treated for TTTS,
which were acquired with the PA imaging system based
FIGURE 5 Photoacoustic (PA) images of the laser photocoagulated (scar) tissue of a TTTS-treated placenta. A, The 3D PA images were
obtained using a Fabry-Pérot based PA scanner and are displayed on a logarithmic scale as maximum intensity projections (MIPs) of the
reconstructed 3D image volume. The scar tissue is a weak absorber for excitation light and thereby provides negative contrast to the image.
The photocoagulation depth is visible in the x-zMIPs. The scale bar applies to all images and axes orientations. B, Corresponding
photograph that includes the locations that were imaged in A. C, An H&E-stained section was obtained from within imaging location
4 (dashed orange line). The photocoagulated tissue depth on histological examination is approximately 1 mm (double black arrow), which is
consistent with that observed from the PA image acquired at the same location in A
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on a clinical linear-array US probe, are presented in
Figure 4. Interleaved co-registered PA and US images were
displayed in real time (Figure 4A). With PA imaging, sev-
eral superficial blood vessels were visualized (Figure 4A;
red arrows), which corresponded well with those apparent
in the photograph (Figure 4B). A prominent signal in the
2D PA image was not apparent in the photograph; it was
also not readily visible in the US image. With US imaging,
a hypoechoic region that likely corresponded to a fluid-
filled cavity (Figure 4A; star region) was not visible with
PA imaging. This cavity potentially arose from water that
leaked around the plastic membrane and may have
entered the placenta from the maternal side. The 3D MIP
PA image (Figure 4C) clearly revealed superficial
branching vessels with good spatial correspondence with
the photograph (Figure 4B).
3.2 | Photocoagulated (scar) tissue
PA images of photocoagulated tissue acquired with the F-P
based PA imaging system are presented in Figure 5. With
PA imaging, negative contrast was obtained from scar tis-
sues (Figure 5A). This decrease in signal with ablation
with some previous studies [41, 42], where ablations led to
reductions in PA signals. However, an increase in the
Grüneisen coefficient with temperature can also result in
an increase in the PA signal strength during real time abla-
tion [43, 44]. The photocoagulation depth across different
locations in the scar was visible in the x-zMIPs, and varied
approximately from 2 to 4 mm. An H&E stained
section obtained from one location (Figure 5B; location 4),
confirmed the photocoagulation depth of approximately
1 mm (Figure 5C), which was found to be consistent with
the corresponding PA image (Figure 5A; location 4).
Wide-field PA images of the scar tissue of a placenta
treated for TTTS, which were acquired with the PA imag-
ing system based on a clinical linear-array US probe, are
presented in Figure 6 In the absence of photocoagulation,
prominent PA signal originated from superficial blood
vessels (Figure 6A; red arrows), and there was good
visual correspondence between the locations of those ves-
sels and the photograph (Figure 6B). With photocoagula-
tion, weak PA signals originating from locations beneath
the scar tissue can be attributed to the relatively lower
absorption of excitation light by the scar tissue as com-
pared with nonphotocoagulated placental tissue. From
the 3D MIP PA image (Figure 6C), superficial chorionic
structures were visualized, and they corresponded well
with the photograph (Figure 6B).
FIGURE 6 Wide-field photoacoustic (PA) and ultrasound
(US) images of tissue of a placenta that was treated for TTTS.
The PA and US images were acquired with the PA/US imaging
system based on a clinical linear array. A, Two frames of
merged 2D PA and US images that were acquired from two
locations: non-treated tissue (dashed blue box in A
corresponding to the dashed blue line in B) and scar tissue from
photocoagulation treatment (dashed green lines). Superficial
blood vessels (red arrows) are visible in the left PA image,
which correspond well with those in the photograph, B. The
placenta was covered with a cling film membrane (yellow
arrow). The images are displayed on logarithmic scales. B, 3D
PA image volume, which was acquired by linear translation of
the US probe and displayed as a maximum intensity projection.
Superficial chorionic structures are visualized, with good
correspondence to the photograph, B
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4 | DISCUSSION
This study provides the first demonstration that volumet-
ric PA imaging of the human placenta can generate
detailed maps of surface and subsurface vasculature to a
depth of approximately 7 mm. Fetoscopic photocoagula-
tion, which was used to stop circulation across placental
anastomoses in the vascular equator from identical twins
during in utero TTTS treatment, was clearly visible. It
manifested as an absence of signal resulting from weak
absorption of PA excitation light in this region.
The two photoacoustic imaging systems used in this
study provided complementary information. The F-P
based PA imaging system provided a much finer level of
detail; the PA imaging system based on a clinical US
probe allowed for rapid 2D imaging and concurrent B-
mode 2D US imaging. US imaging provided structural
imaging that was absent in PA images and it facilitated
interpretation of the PA images. As compared with previ-
ous 2D PA imaging studies in which excitation light was
provided by an optical fiber [32, 33], the 3D PA images
from both systems in this study provided a much more
comprehensive visualization of placental vasculature.
Several questions remain unanswered. First, it is
unclear what PA imaging depth range might be optimal
for clinical use, although it is known that the depth
range of anastomosing vessels in TTTS is quite shallow
(a few mm) [8]. Both systems used here had insufficient
sensitivity to visualize vasculature at all depths in the
placenta, and insufficient spatial resolution to visualize
the smallest vessels. Imaging penetration depth depends
on several factors, including the optical properties of the
imaged tissue, the ultrasound bandwidth and sensitivity
of the F-P sensor, and the physical dimensions of the F-
P sensor. The human placenta is a highly vascularized
tissue and since it was imaged ex vivo, contributions of
deoxy-hemoglobin are likely dominant at 760 nm com-
pared to oxy-hemoglobin, which is more abundant
in vivo. Therefore, penetration depths are likely to be
higher at 760 nm when imaging is performed in vivo.
Typically, lower frequency systems allow for imaging at
greater depths. The penetration depths achieved in this
study reflect high-frequency (high-resolution) imaging
and are broadly consistent with previous studies [26,
34–36]. Next-generation systems could also include
ultrasound receivers with ultra-high sensitivities [45]
and coded excitation sequences [46]. Second, it is
unclear what lateral field of view and spatial resolution
may be required for clinical use. If needed, the lateral
field of view could be increased using actuators such as
those based on McKibben muscles [47], and the use of
haptic guidance [48]. Third, given that volumetric imag-
ing can be time consuming, it remains to be seen
whether it would be efficient to direct it at specific loca-
tions on the placenta. There is variability in the reported
distribution of residual anastomoses across the surface
of placentas, with reports of a higher density at the pla-
cental margin [49] and a relatively uniform spread along
the vascular equator [12]. In current clinical practice,
photocoagulation can be particularly challenging when
there are proximate cord insertions (distance <5 cm
between the two umbilical cord insertions) [50] and
when there are anastomoses away from the placental
vascular equator, particularly those involving small ves-
sels (0.4 ± 0.5 mm) at the edge of the placenta [12]. The
photocoagulation depth and the vasculature are likely to
change during pregnancy. A study by Branisteanu-
Dumitrascu et al [51] measured the in vivo impact of
photocoagulation and found that the local effects of the
photocoagulation did not significantly change over time;
however, there were significant collateral and peripheric
tissue changes. Additionally, secondary changes and col-
lateral damage are limited due to the placental perfusion
and healing as the maternal circulation keeps tissue
components alive.
For clinical translation of PA imaging to guide TTTS
treatment in utero, it will be necessary to develop minia-
ture probes with sufficiently small lateral dimensions that
allow for excitation light delivery through the working
channel of a fetoscope (typically less than 2 mm in diam-
eter [52]) and with real-time imaging [32]. Intraoperative
guidance could be achieved with the development of
miniature, forward-viewing PA and US endoscopic pro-
bes [53–59] in concert with recent developments in real-
time imaging capabilities enabled by parallel data acqui-
sition [36] and compressed sensing [60]. Multispectral PA
imaging, with multiple excitation wavelengths, could be
employed to obtain information about hemoglobin oxy-
gen saturation in the vasculature [16–18] and potentially
to provide insights about the pathophysiology of TTTS
and fetal growth restriction. Additional interventional
procedures that could potentially benefit from the combi-
nation of PA imaging and ultrasound include ablation
monitoring during laser or radiofrequency therapy of
lesions such as those in the heart [41, 44] and in the
liver [42].
In conclusion, PA imaging in 3D appears to be prom-
ising for visualizing human placental vasculature in
healthy and TTTS-treated placentas. Improving the detec-
tion of residual anastomosing vessels at the time of pho-
tocoagulation therapy for TTTS in utero is likely to
improve patient outcomes by achieving complete
dichorionization. By visualizing superficial and subsur-
face chorionic placental vasculature, interventional PA
imaging could be valuable for minimally invasive fetal
therapies.
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